Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
04/22/2003 | US6552223 N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
04/22/2003 | US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
04/22/2003 | US6552188 Unsymmetrical cyclic diamine compound |
04/22/2003 | US6552088 Biphenyl derivatives |
04/22/2003 | US6552081 Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
04/22/2003 | US6552075 Therapeutic compounds and methods of use |
04/22/2003 | US6552071 Methods for treating cell death diseases and inflammation |
04/22/2003 | US6552054 Chromone derivatives, process for the preparation of the same and uses thereof |
04/22/2003 | US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
04/22/2003 | US6552043 Benzimidazolinyl piperidines as CGRP ligands |
04/22/2003 | US6552036 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
04/22/2003 | US6552031 Synergistic analgesic combination of oxycodone and rofecoxib |
04/22/2003 | US6552020 Compositions including antibiotics and methods for using same |
04/22/2003 | US6552019 Inhibitors of p38 |
04/22/2003 | US6552012 Heteroaryl diazabicycloalkanes, their preparation and use |
04/22/2003 | US6552010 Treatment of SLE with dehydroepiandrosterone |
04/22/2003 | US6551822 NL4 tie ligand homologue |
04/22/2003 | US6551615 Capsule containing dexibuprofen (ibuprofen) dissolved in a solubilizer, a potassium salt forming compound, surfactants, co-surfactants, and a viscosity imparter; bioavailability |
04/22/2003 | CA2304784C A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
04/22/2003 | CA2287054C 1,3,8-triazaspiro¬4,5|decanone compounds as orl1-receptor agonists |
04/22/2003 | CA2264960C External formulation containing loxoprofen |
04/22/2003 | CA2253869C Substituted oxobutyric acids as matrix metalloprotease inhibitors |
04/22/2003 | CA2068630C Use of protein c or activated protein c |
04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
04/17/2003 | WO2003031475A2 Antibodies against kdr, their production and uses |
04/17/2003 | WO2003031464A2 Remodeling and glycoconjugation of peptides |
04/17/2003 | WO2003031459A2 Modulation of the expression of genes dependent on stat-1 |
04/17/2003 | WO2003031448A1 Reverse-turn mimetics and method relating thereto |
04/17/2003 | WO2003031447A2 Pyrimidine derivatives |
04/17/2003 | WO2003031438A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
04/17/2003 | WO2003031434A1 Compounds and methods |
04/17/2003 | WO2003031431A1 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
04/17/2003 | WO2003031418A1 3,4-dihydro-1h-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor |
04/17/2003 | WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent |
04/17/2003 | WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS |
04/17/2003 | WO2003031405A2 Methods for the synthesis of substituted purines |
04/17/2003 | WO2003031404A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
04/17/2003 | WO2003031398A1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
04/17/2003 | WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
04/17/2003 | WO2003030944A2 Inhibition of stat-1 |
04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
04/17/2003 | WO2003030939A1 Therapies for treating respiratory diseases |
04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
04/17/2003 | WO2003030930A1 Human 3 relaxin |
04/17/2003 | WO2003030929A1 Combination therapies using methyl donors or methyl donor enhancers and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
04/17/2003 | WO2003030927A2 Use of thymulin-like peptides for making pain-relieving medicines |
04/17/2003 | WO2003030920A1 An antispasmodic agent spaced drug delivery system |
04/17/2003 | WO2003030919A1 Method of obtaining an extract of ginger |
04/17/2003 | WO2003030905A1 Dihydroorotate dehydrogenase inhibitor |
04/17/2003 | WO2003030902A1 Imidazole derivates as anti-inflammatory agents |
04/17/2003 | WO2003030897A1 Pyrrolidinone derivatives |
04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |
04/17/2003 | WO2003030883A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
04/17/2003 | WO2003030882A1 Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made thereform |
04/17/2003 | WO2003030878A2 Galenic microparticulate oral formulation |
04/17/2003 | WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
04/17/2003 | WO2003030875A1 Over-coated chewing gum formulations including tableted center |
04/17/2003 | WO2003030857A1 Enhancing epidermal barrier development in skin |
04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
04/17/2003 | WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis |
04/17/2003 | WO2003030823A2 Combinations for the treatment of immunoinflammatory disorders |
04/17/2003 | WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor |
04/17/2003 | WO2003008457A3 Polysaccharidic esters of retinoic acid |
04/17/2003 | WO2003007875A3 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
04/17/2003 | WO2003005999A3 Methods of treating cytokine mediated diseases |
04/17/2003 | WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
04/17/2003 | WO2002089770A3 Topical lamellar double membrane structure composition containing n-acyl-ethanolamine and/or a quaternary ammonium salt and/or adenosylmethionine |
04/17/2003 | WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof |
04/17/2003 | WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
04/17/2003 | WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them |
04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
04/17/2003 | WO2002069968A8 New use |
04/17/2003 | WO2002050289A9 Methods for the production of multimeric proteins, and related compositions |
04/17/2003 | WO2002047704A9 Herbal pharmaceutical compositions for treating immunological disorders |
04/17/2003 | WO2002044191A3 Anti-inflammatory compounds derived from pseudopterogorgia elisabethae |
04/17/2003 | WO2002033085A3 Wisp polypeptides and therapeutical applications thereof |
04/17/2003 | WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
04/17/2003 | WO2002032445A3 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
04/17/2003 | WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
04/17/2003 | WO2002017881A3 Transdermal pharmaceutical delivery composition |
04/17/2003 | WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands |
04/17/2003 | US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
04/17/2003 | US20030073833 Antiinflammatory agents; anticoagulants |
04/17/2003 | US20030073832 Novel aminophenyl ketone derivatives |
04/17/2003 | US20030073733 Pharmaceutically active compounds and methods of use |
04/17/2003 | US20030073732 Antiinflammatory agents |
04/17/2003 | US20030073727 Central nervous system disorders |
04/17/2003 | US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens |
04/17/2003 | US20030073720 Tryptase inhibitors |
04/17/2003 | US20030073719 Chiral salt resolution |
04/17/2003 | US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |